NCT04756856

Muscle-targeted Nutritional Therapy for the Recovery From COVID-19

Impact of a Muscle-targeted Nutritional Therapy in the Recovery of Post-discharge COVID19 Patients Suffering From Sarcopenia

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 5 (actual)
• Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To assess the impact of a muscle-targeted nutritional therapy consisting of nutritional counseling and high-quality whey protein-based oral nutritional supplements enriched with leucine and vitamin D, on the recovery of post-COVID-19 patients

Conditions

• Sarcopenia

Interventions

Type	Name	Description
OTHER	Muscle-target oral nutritional supplementation	Patients will receive daily for 12 weeks two servings (40 grams each) of powder (Fortifit; Nutricia) which has to be dissolved in 125 ml of water. Per serving, 20 g whey protein, 3 g total leucine, 9 g carbohydrates, 3 g fat, and 800 IU vitamin D. Patients will be also followed for 12 weeks after the suspension of supplementation.

Timeline

• Start date: 2021-04-21
• Primary completion: 2022-05-01
• Completion: 2022-05-03
• First posted: 2021-02-16
• Last updated: 2025-05-01

Locations

1 site across 1 country: Italy